What Is Already Known About This Topic?: Reducing population mobility and increasing the vaccination rate for severe acute respiratory syndrome coronavirus 2 can decrease the transmission of coronavirus disease 2019 (COVID-19).

What Is Added By This Report?: In order to reduce the incidence of COVID-19 to the levels of influenza after restoring normal mobility, the efficacy against infection needs to be increased to 40% and the efficacy against symptomatic disease needs to be increased to 90%. The efficacy against infection has a more important impact compared to efficacy against symptomatic disease or death on the transmission of COVID-19 at the population level.

What Are The Implications For Public Health Practice?: The population should continue maintaining non-pharmaceutical interventions and minimize international movement to prevent transmission of COVID-19. Furthermore, developing new vaccines or promoting booster vaccinations should be considered to increase efficacy.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837462PMC
http://dx.doi.org/10.46234/ccdcw2022.012DOI Listing

Publication Analysis

Top Keywords

population mobility
8
efficacy infection
8
efficacy symptomatic
8
symptomatic disease
8
transmission covid-19
8
efficacy
5
impact regions
4
covid-19
4
regions covid-19
4
covid-19 cases
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!